Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motohiko Tanaka

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Journal of Gastroenterology|April 1, 2021
Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitisJun Itakura, Masayuki Kurosaki, Hiroko Setoyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 18, 2026
Impact of Etiological Shifts and the Rising Burden of Non-B Non-C Hepatocellular Carcinoma on Surveillance and Prognosis: Insights From a 20-Year Retrospective Observational StudyYoko Yoshimaru, Katsuya Nagaoka, Hiroko Setoyama, et al.
Plos One|January 14, 2014
Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseasesKohei Nagumo, Motohiko Tanaka, Victor Tuan Giam Chuang, et al.
Case Reports in Gastroenterology|November 24, 2011
Brain metastasis from gastrointestinal stromal tumor: a case report and review of the literatureHideaki Naoe, Eisuke Kaku, Yumi Ido, et al.
Redox Biology|August 20, 2024
Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activationHiroki Yanagisawa, Hitoshi Maeda, Isamu Noguchi, et al.
Journal of Clinical Laboratory Analysis|June 17, 2026
Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in JapanHiroko Setoyama, Takehisa Watanabe, Shiho Miyase, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 2, 2021
Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASHHitoshi Maeda, Yu Ishima, Junji Saruwatari, et al.
Drug Delivery|April 25, 2018
Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actionsYuki Minayoshi, Hitoshi Maeda, Hiroki Yanagisawa, et al.
International Journal of Cancer|February 21, 2024
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrenceXian-Yang Qin, Yohei Shirakami, Masao Honda, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Gastroenterology|April 1, 2021
Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitisJun Itakura, Masayuki Kurosaki, Hiroko Setoyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 18, 2026
Impact of Etiological Shifts and the Rising Burden of Non-B Non-C Hepatocellular Carcinoma on Surveillance and Prognosis: Insights From a 20-Year Retrospective Observational StudyYoko Yoshimaru, Katsuya Nagaoka, Hiroko Setoyama, et al.
Plos One|January 14, 2014
Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseasesKohei Nagumo, Motohiko Tanaka, Victor Tuan Giam Chuang, et al.
Case Reports in Gastroenterology|November 24, 2011
Brain metastasis from gastrointestinal stromal tumor: a case report and review of the literatureHideaki Naoe, Eisuke Kaku, Yumi Ido, et al.
Redox Biology|August 20, 2024
Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activationHiroki Yanagisawa, Hitoshi Maeda, Isamu Noguchi, et al.
Journal of Clinical Laboratory Analysis|June 17, 2026
Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in JapanHiroko Setoyama, Takehisa Watanabe, Shiho Miyase, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 2, 2021
Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASHHitoshi Maeda, Yu Ishima, Junji Saruwatari, et al.
Drug Delivery|April 25, 2018
Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actionsYuki Minayoshi, Hitoshi Maeda, Hiroki Yanagisawa, et al.
International Journal of Cancer|February 21, 2024
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrenceXian-Yang Qin, Yohei Shirakami, Masao Honda, et al.
Pageof 5